Type 2 Diabetes Prevention: A Review
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
IN BRIEF: This review offers a discussion of various strategies for the prevention of type 2 diabetes. It includes results from recent clinical trials targeting patients who are at highest risk for the development of diabetes, with a particular emphasis on lifestyle modification strategies and the implementation of such programs in community-based settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
Cited by
The IMAGE Study Group, Greaves, C. J., Sheppard, K. E., Abraham, C., Hardeman, W., Roden, M., Evans, P. H., & Schwarz, P. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-119 · Cited by 1,163
Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants
P, S., Zinjarde, S. S., Bhargava, S. Y., & Kumar, A. R. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-5 · Cited by 353
Incidence of Remission in Adults With Type 2 Diabetes: The Diabetes & Aging Study
Karter, A. J., Nundy, S., Parker, M. M., Moffet, H. H., & Huang, E. S. (2014) · Diabetes Care · doi:10.2337/dc14-0874 · Cited by 132
“est risk reduction in diabetes from lifestyle modification (29,30), findings that have particular salience given that the prevalence of type 2 diabetes is highest among the elderly (25).”
BackgroundLimaye, T., Kumaran, K., Joglekar, C., Bhat, D., Kulkarni, R., Nanivadekar, A., & Yajnik, C. (2017) · Diabetic Medicine · doi:10.1111/dme.13258 · Cited by 50
A review of nutritional tracking mobile applications for diabetes patient use.
Darby, A., Strum, M. W., Holmes, E., & Gatwood, J. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0299 · Cited by 46
Metadata
- Authors
- Ahmad, L. A., & Crandall, J. P.
- Venue
- Clinical Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-01-01
- Volume
- 28
- Issue
- 2
- Pages
- 53-59
- ISSN
- 0891-8929 (ISSN-L)
- 1945-4953
- OpenAlex
- W2122329183
- Cited by
- 86
- References
- 23
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.